Beta-ketothiolase deficiency is a rare autosomal recessive disorder characterized by an inborn error of isoleucine catabolism and affecting ketone body metabolism. Clinical features characterized by intermittent keto acidotic episodes are associated with clinical signs and symptoms of toxic encephalopathy such as lethargy, hypotonia, vomiting, tachypnea, and coma in some patients, with an onset during infancy or toddler-hood. A two months old girl presented to pediatric ward of Imam Reza Hospital in Mashhad City, Northwestern Iran in October 2016, with acute episode of fever and toxic encephalopathy with attack of vomiting, hypotonia, lethargy, tonic-clonic seizures and then a day in coma, few days after vaccination. After then similar episodes happened until 7 months age. Bio chemical tests that suggested diagnose of beta ketothiolase deficiency were attacks of ketoacidosis with urinary exertion of 2-methyl-3-hydroxybutyric acid 2-methyl aceto acetic acid tiglylglycine. In genetic assessment, we detected a novel homozygous mutation c.664A> C (p. Ser 222 Arg) in ACAT gene. This is the first report of beta ketothiolase deficiency confirmed by molecular analysis from Iran. We report on a homozygous variant in the ACAT1 gene and that is a novel mutation. We recommended carrier testing for all informative family members to recognize mutations in asymptomatic family members.
Introduction
Beta-ketothiolase deficiency also known as alpha-methyl acetoacetic aciduria, T2 deficiency, mitochondrial acetoacetyl-CoA thiolase deficiency, 3-oxothiolase deficiency and 2-methyl-3-hydroxybutyric acidemia (1) (2) (3) (4) .
The T2 deficiency (as an abbreviation of beta-kethothiolase deficiency) is an autosomal recessive organic aciduria due to the deficiency of mitochondrial beta ketothiolase enzyme affected in pathway of ketone body metabolism and isoleucine catabolism ( Figure 1 ) (5, 6) .
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Currently, more than 100 patients have been reported worldwide with no local predisposition (1) . This rare condition is estimated with an incidence of 1 per 1 million newborns or less (2,7).
This disorder first described in 1971 in 6 years old boy. The presenting clinical feature was severe episodes of metabolic acidosis with increased amounts of alpha-methyl beta-hydroxyl butyric acid in the urine (8) .
The typical clinical features manifest between age of 6 to 18 months in infancy with intermittent attacks of ketoacidosis crisis, vomiting, hypotonia, respiratory distress, convulsion, and lethargy.
Coma, psychomotor retraction and even death have been reported in rare cases (9) . These acute crises can decompensate rapidly in early childhood and lead to neurodevelopmental delay, repeated seizures and death without appropriate treatment (10) .
The episodes often brought on by stress, fasting, acute illness, fever and infection (2) . The frequency of episodes decreases with age and between In rare cases, atypical presentation can happen with having sign and symptoms before age of 6 months, even in neonatal period (12) , also some patients can present with neurological manifestations before a first ketoacidotic crises, however, is very rare (13) . In a descriptive study of 35 patients with T2 deficiency in Vietnam, the most common mutation of ACAT1 gene was R208X (p.Arg208) in 70% of cases, that it is the most common mutation has been identified in the world (21) . Except this mutation in Vietnamese (p.Arg208), no other common ACAT1 mutations have been reported (15) . In
Figure. 2. Brain Magnetic Resonance Imaging shows nonspecific low signal intensity in basal ganglia
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Asian and Arab countries, there are some reports of ACAT1 mutations and novel mutations (Table. 2) (17, (22) (23) (24) (25) (26) . In our study, we found a homozygous mutation c.664A>C (p. ser 222Arg) in ACAT1
gene by whole exome sequencing test, that was a novel mutation, so it has not been reported before.
Today, the DNA analysis of suspected gene in patients with beta ketothiolase deficiency can confirm this disorder. In gene, analysis reveal novel variants in ACAT1 gene that have never been reported, can be enough for diagnosis of betaketothiolase deficiency (7, 26 With the proper management, our patient is in a good condition without any acute episode in recent 2 months.
In conclusion, in patients with beta-ketothiolase On the other hand, challenge of subtle abnormalities in urinary organic acid profile and the necessity of early exact diagnosis emphasis on using genetic assay or an enzymatic analysis to confirm the diagnosis. 
